眼表面疾患の世界市場 (2023年)：調査報告書

当レポートでは、米国・西欧の眼科医および検眼医を対象とした調査 (2023年7月) に基づき、眼表面疾患の診察・検査を行っている患者の動向や、治療法の採用状況、最新の市場動向に関する知見といった情報を取りまとめてお届けいたします。

当社は、Market-Scope.comに自己登録したほとんどの専門分野（白内障、屈折矯正、角膜、緑内障、総合）の開業医に、眼表面疾患に関する年次スポンサー調査への参加を呼びかけました。

調査報告書はあくまでも報告されたデータの要約分析であり、市場全体への追加的な推測は行っておりません。調査データはすべて非識別化され、安全なサーバーで管理されています。

分析内容

調査の質問項目は、Market Scopeが調査スポンサー企業と共同で作成したものです。質問項目は以下の通りですが、これらに限定されるものではありません：

• 眼表面疾患の種類
• ドライアイの重症度と病態
• アレルギー性結膜炎の治療法
• 眼表面疾患の評価に使用される診断薬
• ドライアイの治療に使用される点眼薬と医薬品
• ドライアイに使用される医療機器と代替治療
• 生物製剤の使用

Market Scope surveyed ophthalmologists and optometrists in the United States and Western Europe during July 2023 to measure patients they were seeing and screening for ocular surface disease; adoption of treatments; and insight into the latest market trends.

Practitioners from most specialties (cataract, refractive, cornea, glaucoma, and comprehensive) who self-registered on Market-Scope.com were invited to participate in an annual sponsored survey on ocular surface disease.

An email invitation was sent on July 7, 2023, and last call invitations on July 14 and July 21, 2023. We received 169 total complete, unique responses - 130 from the US and 39 from Western Europe. All results were calculated based on respondent count; because not all questions were applicable to all providers, the respondent count (n) may vary throughout the survey.

Survey reports are strictly a summary analysis of the reported data, and no additional extrapolation to the overall market was performed. All survey data are de-identified and maintained on a secure server.

Contents:

Questions included in the survey were developed by Market Scope in combination with companies that sponsor the survey. Question topics included, but were not limited to, the following:

• Types of ocular surface disease prevalence
• Dry eye severity and pathology
• Allergic conjunctivitis treatments
• Diagnostics used to evaluate ocular surface disease
• Drops and pharmaceuticals used to treat dry eye
• Devices and alternative treatments used for dry eye
• Biologics use